SGAM
ANTH

Smith Group Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Smith Group Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,140
Closed -$152K – 505
2016
Q2 		$152K Buy
6,140
+2,512
+69% +$71K ﹤0.01% 288
2016
Q1 		$105K Buy
3,628
+867
+31% +$23.5K ﹤0.01% 269
2015
Q4 		$102K Buy
2,761
+288
+12% +$12.7K ﹤0.01% 292
2015
Q3 		$120K Buy
2,473
+68
+3% +$4.75K ﹤0.01% 244
2015
Q2 		$166K Buy
+2,405
New +$111K 0.01% 227

Other funds holding ANTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smith Group Asset Management's ANTH Position: Q3 2016 in Review

Smith Group Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2016, closing a stake of 6,140 shares — an estimated $152K sold.

Smith Group Asset Management first reported a position in ANTH in Q2 2015 and held it in 5 quarters. The position peaked at $166K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q3 2016.

  • Smith Group Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Smith Group Asset Management sold 6,140 Anthera Pharmaceuticals, Inc. shares in Q3 2016, an estimated $152K.
  • Smith Group Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
  • Smith Group Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $166K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2016.

Based on Smith Group Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.